The breast imaging devices market consists of sales of breast imaging devices and related services by entities (organizations, sole traders, and partnerships) that manufacture breast imaging devices. Breast imaging devices are medical devices used in the diagnosis of medical conditions related to the breast. Some of the breast imaging processes include mammography, MRI, and ultrasound.
The global breast imaging devices market is expected to decline from $3.51 billion in 2019 to $3.46 billion in 2020 at a compound annual growth rate (CAGR) of -1.45%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $5.07 billion in 2023 at a CAGR of 13.56%.